Identification of protein signatures for lung cancer subtypes based on BPSO method
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0294243 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Jihan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, School of Medicine, Xi'an International University, Xi'an, 710077, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Xi 'an, Engineering Research Center of Personalized Anti-aging Health Product Development and Transformation, Universities of Shaanxi Province, the Key Research and Development Program of Shaanxi Province.
Abstract (Originalsprache)
The objective of this study was to identify protein biomarkers that can distinguish between LUAD and LUSC, critical for personalized treatment plans. The proteomic profiling data of LUAD and LUSC samples from TCPA database, along with phenotype and survival information from TCGA database were downloaded and preprocessed for analysis. We used BPSO feature selection method and identified 10 candidate protein biomarkers that have better classifying performance, as analyzed by t-SNE and PCA algorithms. To explore the causalities among these proteins and their associations with tumor subtypes, we conducted the PCStable algorithm to construct a regulatory network. Results indicated that 4 proteins, MIG6, CD26, NF2, and INPP4B, were directly linked to the lung cancer subtypes and may be useful in guiding therapeutic decision-making. Besides, spearman correlation, Cox proportional hazard model and Kaplan-Meier curve was employed to validate the biological significance of the candidate proteins. In summary, our study highlights the importance of protein biomarkers in the classification of lung cancer subtypes and the potential of computational methods for identifying key biomarkers and understanding their underlying biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Basic Medicine, School of Medicine, Xi'an International University, Xi'an, 710077, China.
- Engineering Research Center of Personalized Anti-aging Health Product Development and Transformation, Universities of Shaanxi Province, Xi'an, 710077, China.
- School of Electronics and Information, Northwestern Polytechnical University, Xi'an, 710129, China.
ORCID-Profile: Yangyang Wang
Förderung
- Science and Technology Planning Project of Xi 'an
- Engineering Research Center of Personalized Anti-aging Health Product Development and Transformation, Universities of Shaanxi Province
- the Key Research and Development Program of Shaanxi Province
- Science and Research Special Project of Education Department of Shaanxi Provincial Project
Zitieren
APA
Wang, J., Wang, H., Xu, J., Song, Q., Zhou, B., Shangguan, J., Xue, M., & Wang, Y. (2023). Identification of protein signatures for lung cancer subtypes based on BPSO method. PLOS ONE. https://doi.org/10.1371/journal.pone.0294243
Vancouver
Wang J, Wang H, Xu J, Song Q, Zhou B, Shangguan J, et al. Identification of protein signatures for lung cancer subtypes based on BPSO method. PLOS ONE. 2023. doi:10.1371/journal.pone.0294243
BibTeX
@article{Wang2023,
author = {Wang, Jihan and Wang, Hanping and Xu, Jing and Song, Qiying and Zhou, Baozhen and Shangguan, Jingbo and Xue, Mengju and Wang, Yangyang},
title = {Identification of protein signatures for lung cancer subtypes based on BPSO method},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0294243}
}
EUVIMED